Related Experiment Video
Updated: Jul 17, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
[Malignant peritoneal mesothelioma]
V Scripcariu1, Elena Dajbog, L Lefter
1Clinica aIII-a Chirurgicală si Centrul de Cercetare in Chirurgia Oncologică si Training in Chirurgie Generală, Spitalul "Sf. Spiridon", U.M.E "Gr. T. Popa" Iasi. vscripcariu@gmail.com
Chirurgia (Bucharest, Romania : 1990)
|February 8, 2007
Summary
This case report details a patient with malignant peritoneal mesothelioma, a rare cancer linked to asbestos exposure. Early diagnosis and surgical intervention were crucial for this aggressive asbestos-related malignancy.
Area of Science:
- Oncology
- Pathology
- Epidemiology
Background:
- Mesothelioma is a rare neoplasm arising from mesothelial cells, affecting serous cavities like the pleura and peritoneum.
- Asbestos exposure is a known etiological factor for malignant mesothelioma, with risk correlating to cumulative exposure.
- Malignant mesothelioma is an aggressive cancer with insidious symptoms, complicating diagnosis and treatment.
Observation:
- A 59-year-old male electrician with a 40-year history of asbestos exposure presented with weight loss, abdominal pain, and fatigue.
- Imaging revealed a large tumor in the upper abdomen, apparently originating from the spleen's superior pole.
- Surgical exploration identified a vascularized, cystic tumor adherent to the diaphragm, spleen, and stomach.
Findings:
- Surgical ablation of the tumor and splenectomy were performed.
- The patient experienced a favorable postoperative recovery.
- The patient is currently undergoing chemotherapy for malignant peritoneal mesothelioma.
Implications:
- This case highlights the importance of considering asbestos exposure in patients with unexplained abdominal malignancies.
- Aggressive surgical management combined with adjuvant chemotherapy can be effective for malignant peritoneal mesothelioma.
- Further research into the long-term outcomes and optimal treatment strategies for peritoneal mesothelioma is warranted.
